Immunovant IMVT
NASDAQ IMVT
$33.90 +0.13 (+0.37%)
As of: Oct 1, 2026 · 10:07 AM EDT

Immunovant (IMVT) Times Interest Earned (2019)

Updated

Immunovant's Times Interest Earned was -105.07 in FY2020 (year ended Mar 31, 2020).

Analysis

Immunovant (IMVT) Times Interest Earned (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immunovant 6.97 Bn 6.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -28.78
Sep 30, 2019 -1.69
API Access

Immunovant Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=IMVT&period=max&api_key=YOUR_API_KEY